adch3nsmut1

Vaccineexperimental

Clinical trial activity

6 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
6
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2007 (NCT01070407)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • adch3nsmut1

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02568332Phase 1Jun 1, 2015Cantonal Hospital of St. Gallen, GlaxoSmithKline, ReiThera Srl, St. James's Hospital, Dublin, Trinity College Dublin, University of Oxford
NCT02362217Phase 1Oct 1, 2014GlaxoSmithKline, ReiThera Srl, University of Oxford
NCT01436357Phase 1/Phase 2 (Phase 2)Mar 6, 2012National Institute of Allergy and Infectious Diseases (NIAID)
NCT01296451Phase 1Dec 1, 2010ReiThera Srl, University of Birmingham, University of Oxford, Wycombe Hospital, High Wycombe, Buckinghamshire
NCT01094873Phase 1Nov 1, 2009ReiThera Srl, University of Birmingham, University of Oxford
NCT01070407Phase 1Jul 1, 2007ReiThera Srl, University of Birmingham, University of Oxford
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
ReiThera SrlFor profit5312007
University of OxfordAcademic/Hospital5212007
University of BirminghamAcademic/Hospital3012007
GlaxoSmithKlineFor profit2012014
Cantonal Hospital of St. GallenAcademic/Hospital1012015
National Institute of Allergy and Infectious Diseases (NIAID)Government1112012
St. James's Hospital, DublinAcademic/Hospital1012015
Trinity College DublinAcademic/Hospital1012015
Wycombe Hospital, High Wycombe, BuckinghamshireAcademic/Hospital1012010
9 organizations
Page 1 / 1